17P Cyclophosphamide influence on survival probability of breast cancer patients depending on leukotriene receptor LTB4R gene expression level von Kalinkin, A.I., Sigin, V.O., Tanas, A.S., Strelnikov, V.V.

Volltext

Leukotriene B4 receptors abnormal gene expression is associated with either shorter or longer survival in breast cancer patients depending on the intrinsic tumour molecular subtype von Kalinkin, A.I., Nemtsova, M.V., Zaletaev, D.V., Sigin, V.O., Ignatova, E., Kuznetsova, E.B., Strelnikov, V.V., Tanas, A.S.

Volltext

27P Development of DNA methylation markers panels for neoadjuvant chemotherapy response prediction in triple-negative breast cancer von Sigin, V.O., Kalinkin, A.I., Ignatova, E., Chesnokova, G., Vinogradov, I.Y., Vinogradov, I.I., Vinogradov, M.I., Strelnikov, V.V., Zaletaev, D.V., Tanas, A.S.

Volltext

A seven-gene methylation markers panel: An epigenetic predictor of neoadjuvant chemotherapy sensitivity in triple-negative breast cancer von Sigin, V.O., Kalinkin, A.I., Ignatova, E., Sycheva, A.V., Vinogradov, I.I., Vinogradov, M.I., Vinogradov, I.Y., Zaletaev, D.V., Strelnikov, V.V., Tanas, A.S.

Volltext

XmaI-RRBS DNA methylation screening resolves breast cancer epigenetic heterogeneity von Tanas, A.S., Kekeeva, T., Sigin, V.O., Kuznetsova, E.B., Poddubskaya, E., Trotsenko, I., Zaletaev, D.V., Strelnikov, V.V.

Volltext

DNA methylation markers of breast cancer response to anthracycline based neoadjuvant chemotherapy von Sigin, V.O., Strelnikov, V.V., Litviakov, N.V., Simonova, O.A., Volodin, I.V., Slonimskaya, E.M., Tanas, A.S., Zaletaev, D.V., Kuznetsova, E.B., Tsyganov, M.M.

Volltext